(Q38482034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Radiation dose as a risk factor for malignant melanoma following childhood cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

S Guérin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

A Dupuy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

H Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

A Shamsaldin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

G Svahn-Tapper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

T Moller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

S Garwicz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

M Hawkins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

M F Avril

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

O Oberlin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J Chavaudra

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

F de Vathaire

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

2379-2386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

The long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Melanoma as a second malignant neoplasm after childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Physical factors affecting absorbed dose to the skin from cobalt-60 gamma rays and 25-MV x rays

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Surface dose for megavoltage photon beams outside the treatment field

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Surface effects of high-energy X rays at oblique incidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Radiation-induced skin cancer in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Skin tumor risk among atomic-bomb survivors in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Investigation of an excess of melanoma among employees of the Lawrence Livermore National Laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Case-control study of malignant melanoma among employees of the Lawrence Livermore National Laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Epidemiologic studies of pilots and aircrew

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Prevalence of naevocytic naevi after chemotherapy for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Melanocytic naevi and melanoma in survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

p16 overexpression: a potential early indicator of transformation in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

Mortality from second tumors among long-term survivors of retinoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900663-4

7 January 2021

10.1016/S0959-8049(03)00663-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14556931%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference